Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8FU05

Entry ID Method Resolution Chain Position Source
AF-Q8FU05-F1 Predicted AlphaFoldDB

No variants for Q8FU05

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8FU05

No associated diseases with Q8FU05

5 regional properties for Q8FU05

Type Name Position InterPro Accession
domain Pyruvate carboxyltransferase 32 - 312 IPR000891
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 39 - 55 IPR002034-1
conserved_site Alpha-isopropylmalate/homocitrate synthase, conserved site 242 - 255 IPR002034-2
domain 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain 438 - 569 IPR013709
domain LeuA, N-terminal catalytic TIM barrel domain 31 - 314 IPR039371

Functions

Description
EC Number 2.3.3.13 Acyl groups converted into alkyl groups on transfer
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
2-isopropylmalate synthase activity Catalysis of the reaction: 3-methyl-2-oxobutanoate + acetyl-CoA + H(2)O = (2S)-2-isopropylmalate + CoA + H(+).

1 GO annotations of biological process

Name Definition
leucine biosynthetic process The chemical reactions and pathways resulting in the formation of leucine, 2-amino-4-methylpentanoic acid.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MPVKRYLPFE VEVEDITLPD RTWPDKKITQ APQWCAVDLR DGNQALIDPM SPERKRRMFE
70 80 90 100 110 120
LLVKMGFKEI EVGFPSASQT DFDFVREIIE KNMIPDDVTI QVLVQAREHL IRRTFEACEG
130 140 150 160 170 180
AKNVIVHFYN STSILQRDVV FRMNKDQVKT LATDAAELIK TIAQDYPDTN WRWEYSPESY
190 200 210 220 230 240
TGTEVEYAKE VVDAVVEVMD PTPENPIIIN LPATVEMITP NVYADSIEWM HRNLNRRDSI
250 260 270 280 290 300
ILSLHPHNDR GTGVAAAELG YMAGADRIEG CLFGNGERTG NVCLVTLALN MLTQGVDPQL
310 320 330 340 350 360
DFSDIKHIRR TVEYCNQLRV PERHPYGGDL VFTAFSGSHQ DAINKGLDAL AAKVKPGASS
370 380 390 400 410 420
TEVAWEELRS TEWEVPYLPI DPKDVGRDYE AVIRVNSQSG KGGVAYIMKT DHGLKMPRSM
430 440 450 460 470 480
QVEFSAVVQN VTDAEGGEVN SKEMWDIFAT EYLDRSAPVE QIALRVENAQ TENDDATITA
490 500 510 520 530 540
ELVVDGENQT VSGRGNGPLA AYANALESLN IDVEIQEYSQ HARTSGDDAE AAAYVLAEVN
550 560 570 580
GRMVWGVGIA GSITYASLKA VTSAVNRALD FKHQQLQNGG V